Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.7090
+0.0169 (2.44%)
At close: Sep 29, 2026, 4:00 PM EDT
0.6812
-0.0278 (-3.92%)
After-hours: Sep 29, 2026, 4:50 PM EDT
Envoy Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.21 | 0.23 | 0.24 | 0.21 | 0.22 | 0.21 | 0.23 | 0.28 | 0.3 | 0.3 | 0.32 | 0.24 | 0.22 | 0.21 | 0.24 | 0.31 | |
Revenue Growth (YoY) | -6.76% | 10.38% | 7.11% | -25.18% | -26.49% | -28.62% | -28.80% | 15.35% | 38.53% | 38.78% | 33.33% | - | - | - | -23.55% | - |
Cost of Revenue | 0.82 | 0.77 | 0.68 | 0.82 | 0.8 | 0.82 | 0.74 | 0.82 | 0.85 | 0.77 | 0.79 | 0.71 | 0.4 | 0.46 | 0.5 | 0.77 |
Gross Profit | -0.61 | -0.54 | -0.44 | -0.61 | -0.58 | -0.6 | -0.52 | -0.54 | -0.55 | -0.47 | -0.47 | -0.47 | -0.19 | -0.25 | -0.26 | -0.46 |
Selling, General & Admin | 8.8 | 9.02 | 9.15 | 9.42 | 8.66 | 8.31 | 8.56 | 10.13 | 9.47 | 9.61 | 8.93 | 6.73 | 6.12 | 4.57 | 3.47 | 2.47 |
Research & Development | 14.03 | 13.38 | 12.49 | 10.4 | 10.46 | 10.57 | 10.18 | 10.76 | 9.83 | 9.39 | 8.96 | 7.34 | 6.65 | 5.86 | 4.98 | 3.94 |
Operating Expenses | 22.82 | 22.4 | 21.64 | 19.82 | 19.12 | 18.88 | 18.74 | 20.89 | 19.3 | 19 | 17.89 | 14.08 | 12.77 | 10.42 | 8.45 | 6.41 |
Operating Income | -23.43 | -22.93 | -22.08 | -20.43 | -19.7 | -19.48 | -19.26 | -21.43 | -19.84 | -19.47 | -18.36 | -14.54 | -12.95 | -10.67 | -8.71 | -6.87 |
Interest Expense | -0.47 | -1.1 | -1.59 | -1.97 | -1.77 | -1.28 | -0.82 | -0.43 | -0.17 | -0.04 | - | - | - | - | - | - |
Other Non Operating Income (Expenses) | 0.69 | 1.11 | 0.1 | 0.62 | 0.2 | 1.23 | -0.72 | 0.79 | 19.7 | 0.52 | 1.77 | -1.54 | -19.27 | -0.17 | -0.13 | -1.8 |
EBT Excluding Unusual Items | -23.21 | -22.92 | -23.57 | -21.79 | -21.27 | -19.52 | -20.8 | -21.07 | -0.31 | -18.98 | -16.59 | -16.08 | -32.23 | -10.84 | -8.83 | -8.67 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0 |
Other Unusual Items | -0.19 | -0.19 | -0.19 | - | - | - | - | - | -13.33 | -3.96 | -13.33 | -20.42 | -7.09 | -16.47 | -7.09 | - |
Pretax Income | -23.4 | -23.11 | -23.76 | -21.79 | -21.27 | -19.52 | -20.8 | -21.07 | -13.64 | -22.94 | -29.92 | -36.5 | -39.32 | -27.31 | -15.92 | -8.68 |
Net Income | -23.4 | -23.11 | -23.76 | -21.79 | -21.27 | -19.52 | -20.8 | -21.07 | -13.64 | -22.94 | -29.92 | -36.5 | -39.32 | -27.31 | -15.92 | -8.68 |
Preferred Dividends & Other Adjustments | 5.06 | 5.02 | 4.91 | 6.82 | 6.94 | 7.05 | 7.18 | 5.46 | 4.08 | 2.71 | 1.35 | - | -1 | -0.5 | - | - |
Net Income to Common | -28.46 | -28.13 | -28.66 | -28.61 | -28.2 | -26.57 | -27.97 | -26.53 | -17.72 | -25.65 | -31.27 | -36.5 | -38.32 | -26.81 | -15.92 | -8.68 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 56 | 35 | 23 | 21 | 20 | 19 | 19 | 19 | 17 | 14 | 12 | 10 | 139 | 139 | 10 | 10 |
Shares Outstanding (Diluted) | 56 | 35 | 23 | 21 | 20 | 19 | 19 | 19 | 17 | 14 | 12 | 10 | 139 | 139 | 10 | 10 |
Shares Change (YoY) | 177.04% | 80.58% | 23.78% | 12.58% | 21.98% | 35.09% | 52.83% | 83.66% | -88.12% | -89.64% | 21.46% | - | - | - | -0.04% | - |
EPS (Basic) | -0.51 | -0.80 | -1.23 | -1.36 | -1.40 | -1.36 | -1.49 | -1.42 | -1.07 | -1.78 | -2.54 | -3.60 | -0.28 | -0.19 | -1.57 | -0.86 |
EPS (Diluted) | -0.51 | -0.80 | -1.23 | -1.36 | -1.40 | -1.36 | -1.49 | -1.43 | -1.07 | -1.78 | -2.54 | -3.60 | -0.28 | -0.19 | -1.57 | -0.86 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -21.71 | -20.71 | -18.38 | -17.08 | -15.99 | -16.96 | -18.93 | -25.54 | -21.26 | -19.87 | -17.24 | -8.5 | -12.09 | -10.09 | -9.02 | -7.06 |
Free Cash Flow Per Share | -0.39 | -0.59 | -0.79 | -0.81 | -0.79 | -0.87 | -1.01 | -1.37 | -1.29 | -1.38 | -1.40 | -0.84 | -0.09 | -0.07 | -0.89 | -0.70 |
Gross Margin | -293.72% | -229.49% | -183.82% | -294.23% | -262.16% | -284.43% | -229.78% | -194.60% | -181.46% | -158.25% | -149.68% | -192.95% | -85.32% | -114.95% | -110.13% | -148.06% |
Operating Margin | -11319.32% | -9800.00% | -9161.83% | -9824.04% | -8872.97% | -9188.21% | -8558.22% | -7708.63% | -6570.53% | -6556.23% | -5809.81% | -6034.02% | -5941.74% | -4984.58% | -3673.42% | -2216.45% |
Profit Margin | -13747.34% | -12020.09% | -11892.95% | -13755.29% | -12704.51% | -12534.91% | -12432.44% | -9543.52% | -5867.22% | -8637.37% | -9895.89% | -15146.89% | -17575.69% | -12525.70% | -6718.56% | -2798.39% |
Free Cash Flow Margin | -10488.41% | -8850.43% | -7626.56% | -8211.54% | -7201.35% | -8000.94% | -8412.89% | -9186.33% | -7040.73% | -6690.91% | -5456.96% | -3526.14% | -5545.41% | -4714.49% | -3807.17% | -2277.74% |
EBITDA | -23.13 | -22.62 | -21.78 | -20.16 | -19.46 | -19.28 | -19.08 | -21.26 | -19.69 | -19.33 | -18.23 | -14.43 | -12.85 | -10.58 | -8.63 | -6.8 |
D&A For EBITDA | 0.3 | 0.31 | 0.3 | 0.27 | 0.24 | 0.2 | 0.17 | 0.17 | 0.15 | 0.14 | 0.13 | 0.11 | 0.1 | 0.09 | 0.08 | 0.07 |
EBIT | -23.43 | -22.93 | -22.08 | -20.43 | -19.7 | -19.48 | -19.26 | -21.43 | -19.84 | -19.47 | -18.36 | -14.54 | -12.95 | -10.67 | -8.71 | -6.87 |